NCT07879872 Conducting Wound, Ostomy, and Continence (WOC) Nurse Telephone Follow-up for Post-discharge Ostomy Patients to Reduce Hospital Readmission
| NCT ID | NCT07879872 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Ostomy |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2026-11-01 |
| Primary Completion | 2028-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500 participants in total. It began in 2026-11-01 with a primary completion date of 2028-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research is to assess the impact of a telephone follow-up visit on rehospitalizations after ostomy surgery.
Eligibility Criteria
Inclusion Criteria: * All adult patients with new ostomy * Able to consent to participate in the study * English speaking * Patients who are willing to participate Exclusion Criteria: • ostomy revision surgery
Contact & Investigator
Mary Josephine Famorca, DNP
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT07879872 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Ostomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07879872 currently recruiting?
Yes, NCT07879872 is actively recruiting participants. Contact the research team at Famorca.Mary@mayo.edu for enrollment information.
Where is the NCT07879872 trial being conducted?
This trial is being conducted at Phoenix, United States.
Who is sponsoring the NCT07879872 clinical trial?
NCT07879872 is sponsored by Mayo Clinic. The principal investigator is Mary Josephine Famorca, DNP at Mayo Clinic. The trial plans to enroll 500 participants.